ASPNAT and neuroblastoma: In an N2A mouse neuroblastoma cell-line transfection model, we used Nat8l shRNAs under control of the strong RNA pol III U6 promoter and separately used the corresponding target sequences designed as micro (mi)RNAs driven from RNA pol II promoters including CMV, CAG or Synapsin (SYN; Figure 1C).